Sort
23,748 grants matching “melanoma”
Delivery of GPNMB Therapeutics for Bone Regeneration
$394,202Moses O Oyewumi · Northeast Ohio Medical University · R01 · FY2025 · AR
MYC-dependent loss of splicing fidelity in Glioblastoma multiforme
$394,201Patrick Paddison · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Lymphocyte and inflammatory cytokine markers of response in the first-in-human combination of anti-PD-1 mAb and IL-15/IL-15Ra complexes and investigation of mediators of anti-tumor immune responses
$394,181Mark P Rubinstein · Medical University Of South Carolina · R01 · FY2019 · CA
Structure and Function of Thrombospondin-1
$394,169Beth Israel Deaconess Medical Center · R01 · FY2002 · HL
Targeted Chemoprevention for Melanoma
$394,108Gavin P. Robertson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2014 · CA
Biochemistry of Melanins and Photoprotection of the Skin
$394,084Vincent J Hearing · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Function of IL35+ B cells in pancreatic cancer
$394,032Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill · R37 · FY2023 · CA
B cell depletion to prevent autoimmunity
$393,969Kavita Dhodapkar · Emory University · R01 · FY2023 · AR
Molecular Mechanisms of Telomere Length Homeostasis
$393,963Feng Qiao · University Of California-Irvine · R01 · FY2019 · GM
Molecular Mechanisms of Telomere Length Homeostasis
$393,963Feng Qiao · University Of California-Irvine · R01 · FY2020 · GM
Endothelial Transdifferentiation of Invasive Tumor Cells
$393,942Mary J.c. Hendrix · Lurie Children'S Hospital Of Chicago · R37 · FY2010 · CA
Endothelial Transdifferentiation of Invasive Tumor Cells
$393,942Mary J.c. Hendrix · Lurie Children'S Hospital Of Chicago · R37 · FY2009 · CA
Endothelial Transdifferentiation of Invasive Tumor Cells
$393,939Mary J.c. Hendrix · Lurie Children'S Hospital Of Chicago · R37 · FY2008 · CA
Chemiexcitation: A New Mode of Skin Disease
$393,898Douglas E Brash · Yale University · R01 · FY2018 · AR
The integrated stress response and the microenvironment in melanoma progression
$393,894Constantinos Koumenis · University Of Pennsylvania · R01 · FY2024 · CA
Eradication of Escaped Variant Tumor Cells for Cancer Immunotherapy
$393,863Yong Lu · Methodist Hospital Research Institute · R01 · FY2022 · CA
Investigating the HSF1 Cancer Network
$393,849Sandro Santagata · Brigham And Women'S Hospital · R01 · FY2019 · CA
Cell lineage and transcriptional analysis of the vertebrate neural plate border
$393,834Marianne Bronner-Fraser · California Institute Of Technology · R01 · FY2022 · DE
Clonal analysis of the cranial neural crest
$393,834Marianne Bronner-Fraser · California Institute Of Technology · R01 · FY2022 · DE
Development of anti-angiogenesis therapy targeting integrin
$393,783Zhi-Ren Liu · Georgia State University · R01 · FY2016 · CA
Tailored Intervention for Melanoma Patients' Families
$393,773Sharon L Manne · Fox Chase Cancer Center · R01 · FY2006 · CA
Preventing MAPK inhibitor resistance in melanoma by targeting genomic instability and immune resistance
$393,750Roger S Lo · University Of California Los Angeles · R01 · FY2025 · CA
Preventing MAPK inhibitor resistance in melanoma by targeting genomic instability and immune resistance
$393,750Roger S Lo · University Of California Los Angeles · R01 · FY2024 · CA
The mutational mechanisms shaping melanocytes in human skin
$393,718Alan Hunter Shain · University Of California, San Francisco · R01 · FY2025 · AR
Core 1: Biospecimen and Translational Pathology Core
$393,701Arivarasan Karunamurthy · University Of Pittsburgh At Pittsburgh · P50 · FY2025 · CA